Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation

International Journal of Radiation Oncology, Biology, Physics

Volumn 21, Issue 4, 1991, Pages 969-974

  Teicher, Beverly A ^a   Herman, Terence S ^a   Hopkins, Robert E ^a   Menon, Krishna ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Fluosol DA; Hemoglobin; Radiation sensitization; Radiation sensitizers; Tumor hypoxia

Indexed keywords

BIS(PERFLUOROBUTYL)ETHYLENE; FLUOSOL DA; HEMOGLOBIN; PERFLUORO COMPOUND; THEROX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPOXIA; LEWIS CARCINOMA; MOUSE; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANIMAL; CATTLE; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FIBROSARCOMA; FLUOROCARBONS; HEMOGLOBINS; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OXYGEN; RADIATION-SENSITIZING AGENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026091775     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(91)90737-O     Document Type: Article

References (45)

1. Interactions of organic phosphates with bovine hemoglobin I Oxylabile and phosphate-labile proton binding
2. Differences in the interaction of 2,3 diphosphoglycerate with certain mammalian hemoglobins
3. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure
4. Hemoglobin II immunogenic properties of stroma vs. stroma-free hemoglobin solution
5. Oxygen-binding and immunological properties of complexes between dextran and animal hemoglobins
6. Attempts to find a method to prepare artificial hemoglobin corpuscles
7. Red blood cell substitutes: microencapsulated hemoglobin and cross-linked hemoglobin including pyridoxylated polyhemoglobin and conjugated hemoglobin
8. Mechanisms of toxicity of hemoglobin solutions
9. Substitutes for blood and its components
10. La solution d'hemoglobine comme transporteur d'oxigen
11. Hemoglobin-OZ affinity regulation: DPF, monovalent ions, and hemoglobin concentration
12. Effects of Fluosol-DA and carbogen on the radioresponse of SCK tumors and skin of A/J mice
13. Phase I–II study of Fluosol-DA and 100% oxygen breathing as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck
14. Effect of a perfluorochemical emulsion on the radiation response of BA 1112 rhabdomyosarcomas
15. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen
16. Applicability of animal tumor data to cancer therapy in humans
17. Tumor sensitization by the intermittent use of perfluorochemical emulsions and carbogen breathing in fractionated radiotherapy
18. Antigenicity of hemoglobin and its constituents
19. Distribution of acid-soluble phosphorous in the blood cells of various vertebrates
20. The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays
21. Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships
22. Soluability and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications
23. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion
24. A clinical trial of Fluosol-DA 20% in advanced squamous cell carcinoma of the head and neck
25. Testing therapeutic hypotheses in mice and man: observations on the therapeutic activity against advanced solid tumors of man
26. Tumor size dependence in the radiation response of the Lewis lung carcinoma
27. Erythrocyte substitute for perfusion of brain
28. 2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen
29. Influence of tumor size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumor
30. Combined radiotherapy-chemotherapy of Lewis lung carcinoma
31. Effect of Fluosol-DA/carbogen on etoposide/aklylating agent antitumor activity
32. The effect of Fuosol-DA and oxygenation status on the activity of cyclophosphamide in vivo
33. Optimization of perfluorochemical levels with radiation therapy
34. Influence of scheduling dose and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy
35. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma
36. Effects of Fluosol®-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice
37. Approaches to defining the mechanism of Fluosol-DA 20% with carbogen enhancement of melphalan antitumor activity
38. 2 on tumor cell and bone marrow cytotoxicity of nitrosoureas in mice bearing FSaIIC fibrosarcoma
39. Perfluorochemical emulsions can increase tumor radiosensitivity
40. Sensitization of solid mouse tumor to x-ray treatment by oxygen-carrying perfluorochemical emulsion
41. Effect of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion Fluosol-DA
42. Evaluation of human and bovine modifiedhemoglobin solution as oxygen carrying fluid for blood volume replacement
43. Optimal hematologic variables for oxygen transport including P50, hemoglobin cooperativity, hematocrit, acid-base status, and cardiac function
44. Increased radiosensitivity of tumors by per fluorochemicals and carbogen